Retail Giants: Columbia Care

Published on Marijuana Venture   Columbia Care is growing into one of the largest cannabis companies in the world. It already has dispensaries and cultivation facilities in eight states and licenses in place to expand into another four. “We’re expanding quickly and over half the portfolio are in the late stages of opening or are Read More

Metrofocus: Cuomo Announces New Group to Regulate Pot Market

Published on Thirteen on August 7, 2018  

Columbia Care wins 2018 Tribeca Disruptive Innovation Awards for its work to combat the opioid crisis

Columbia Care Introduces Proprietary, Pharmaceutical-Quality, Long-Lasting Medical Cannabis EleCeed™ Tablets

EleCeed is the nation’s first precisely-dosed medication that combines equal levels of THC and CBD with a balanced portfolio of secondary cannabinoids delivered in a long-lasting pharmaceutical-quality hard-pressed tablet The patent-pending pre-scored tablets are now available in 15- and 30-count bottles to patients throughout New York EleCeed tablets are engineered to address the needs of Read More

Columbia Care Receives Authorization from the Florida Department of Health Office of Medical Marijuana Use to Begin Dispensing Its Cannabis-Based Products

The company is offering home delivery to patients registered with Florida’s Office of Medical Marijuana Use   ARCADIA, FL – July 5, 2018 – Columbia Care LLC, the nation’s leading medical cannabis company, announced that it has been authorized to begin dispensing the company’s pharmaceutical-quality cannabis-based medicines in Florida. The company is now offering home Read More

Beyond the Baggie: High Hopes for Nasal Delivery of Medical Cannabis

Published on MD+DI on June 25 by Amanda Pedersen   What happens when a leading medical cannabis company hooks up with a respiratory device company? Dose-metered, nasally-delivered cannabis-based medicines, according to Columbia Care and Rhinomed. The two companies have inked a licensing agreement for the collaborative development of just such a product. New York-based Columbia Read More

Columbia Care Appoints Global Bioinformatics and Healthcare Leaders to Scientific Advisory Board

Published on June 25 on GlobeNewswire Carlos D. Bustamante, Ph.D., Professor and Chair of Biomedical Data Science at Stanford University, and Stephen B. Bonner, Former President and CEO of Cancer Treatment Centers of America and Harvard Business School Entrepreneur in Residence, Join Columbia Care NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) — Columbia Care LLC, Read More

Columbia Care, a Vertically Integrated Medical Cannabis Company, Opens Its First Dispensary in Delaware

Columbia Care is the first medical cannabis operator in Delaware to offer pharmaceutical-quality cannabis-based medicines SMYRNA, DE – June 26, 2018 – Columbia Care LLC, the nation’s largest and most experienced medical cannabis company, announced that it will open its first medical cannabis dispensary in Delaware to qualifying patients on Friday, June 29, 2018. The Read More

Columbia Care mentioned in Bioworld

BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. Columbia Care’s collaboration with Rhinomed to develop nasally delivered cannabis-based medicines was recently featured.   For more information, visit http://www.bioworld.com/.

Columbia Care and Rhinomed Enter into Exclusive Agreement to Develop Nasally-Delivered Cannabis-Based Products

NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) — Columbia Care, LLC, the nation’s leading medical cannabis company, announced that it has entered into a licensing agreement with Australia-based nasal respiratory company Rhinomed (ASX:RNO) for the collaborative development of nasally-delivered cannabis-based medicines. Columbia Care has exclusive rights to develop, import, market, promote, distribute and sell the Read More